| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
45,923 |
40,870 |
$2.26M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
20,808 |
18,977 |
$1.60M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
9,114 |
8,824 |
$748K |
| L3000 |
Foot, insert, removable, molded to patient model, 'ucb' type, berkeley shell, each |
3,331 |
1,431 |
$661K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
5,581 |
5,351 |
$637K |
| 76872 |
|
4,093 |
3,782 |
$295K |
| 52224 |
|
1,091 |
990 |
$272K |
| 95913 |
|
1,152 |
1,003 |
$222K |
| 95886 |
|
1,427 |
1,247 |
$189K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
4,084 |
3,834 |
$150K |
| 76770 |
|
2,124 |
1,965 |
$127K |
| 73620 |
|
4,291 |
2,436 |
$96K |
| 99401 |
|
3,469 |
2,423 |
$68K |
| 99442 |
|
1,278 |
1,093 |
$61K |
| 99223 |
Prolong inpt eval add15 m |
721 |
653 |
$58K |
| 95813 |
|
175 |
169 |
$56K |
| 52000 |
|
478 |
468 |
$48K |
| 11720 |
|
3,592 |
3,383 |
$48K |
| 51798 |
|
8,778 |
8,040 |
$48K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,177 |
1,059 |
$43K |
| 11721 |
|
1,870 |
1,825 |
$40K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
205 |
198 |
$35K |
| 11056 |
|
1,800 |
1,722 |
$34K |
| 95716 |
|
14 |
14 |
$31K |
| 11102 |
|
332 |
318 |
$30K |
| 99205 |
Prolong outpt/office vis |
213 |
211 |
$30K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
822 |
366 |
$28K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
348 |
348 |
$26K |
| 11100 |
|
217 |
200 |
$22K |
| 51741 |
|
1,076 |
1,018 |
$21K |
| 95117 |
|
1,654 |
726 |
$21K |
| 11104 |
|
173 |
169 |
$21K |
| 11900 |
|
402 |
373 |
$20K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
55 |
53 |
$20K |
| 76775 |
|
783 |
707 |
$18K |
| 73630 |
|
464 |
357 |
$11K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,164 |
772 |
$10K |
| 90746 |
|
189 |
172 |
$10K |
| 81002 |
|
18,434 |
16,387 |
$9K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
909 |
801 |
$9K |
| 20611 |
|
135 |
115 |
$9K |
| 95912 |
|
42 |
41 |
$8K |
| 36415 |
Collection of venous blood by venipuncture |
4,214 |
3,999 |
$8K |
| G0127 |
Trimming of dystrophic nails, any number |
1,624 |
1,375 |
$7K |
| A5500 |
For diabetics only, fitting (including follow-up), custom preparation and supply of off-the-shelf depth-inlay shoe manufactured to accommodate multi-density insert(s), per shoe |
363 |
166 |
$7K |
| 76857 |
|
546 |
412 |
$6K |
| A5512 |
For diabetics only, multiple density insert, direct formed, molded to foot after external heat source of 230 degrees fahrenheit or higher, total contact with patient's foot, including arch, base layer minimum of 1/4 inch material of shore a 35 durometer or 3/16 inch material of shore a 40 durometer (or higher), prefabricated, each |
269 |
126 |
$6K |
| 95720 |
|
14 |
14 |
$5K |
| 95700 |
|
27 |
26 |
$5K |
| 73562 |
|
158 |
153 |
$5K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
27 |
27 |
$5K |
| 11103 |
|
61 |
61 |
$5K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
37 |
36 |
$4K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
26 |
26 |
$4K |
| 17110 |
|
34 |
28 |
$3K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
17 |
17 |
$3K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
138 |
135 |
$3K |
| 95812 |
|
12 |
12 |
$3K |
| S0395 |
Impression casting of a foot performed by a practitioner other than the manufacturer of the orthotic |
105 |
50 |
$3K |
| 87653 |
|
205 |
198 |
$3K |
| 87481 |
|
204 |
197 |
$3K |
| 11101 |
|
49 |
45 |
$3K |
| 99354 |
|
32 |
30 |
$3K |
| 93890 |
|
17 |
15 |
$3K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,010 |
927 |
$3K |
| 93886 |
|
15 |
15 |
$3K |
| 88121 |
|
220 |
166 |
$2K |
| 90686 |
|
154 |
142 |
$2K |
| 81001 |
|
1,125 |
1,074 |
$2K |
| 90658 |
|
103 |
99 |
$2K |
| 11719 |
|
497 |
493 |
$2K |
| 93892 |
|
17 |
15 |
$2K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
1,053 |
715 |
$2K |
| 81003 |
|
3,992 |
3,739 |
$2K |
| 92557 |
|
71 |
66 |
$2K |
| 99215 |
Prolong outpt/office vis |
20 |
19 |
$2K |
| 88341 |
|
42 |
41 |
$1K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
167 |
145 |
$1K |
| 99385 |
|
13 |
12 |
$1K |
| 99222 |
Initial hospital care, per day, moderate complexity |
16 |
16 |
$1K |
| 99443 |
|
31 |
27 |
$1K |
| L1902 |
Ankle orthosis, ankle gauntlet or similar, with or without joints, prefabricated, off-the-shelf |
12 |
12 |
$980.01 |
| 88360 |
|
208 |
167 |
$967.61 |
| 88342 |
|
400 |
319 |
$919.41 |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
55 |
55 |
$827.22 |
| 11055 |
|
28 |
26 |
$798.78 |
| 20610 |
|
18 |
16 |
$729.80 |
| J1071 |
Injection, testosterone cypionate, 1 mg |
441 |
169 |
$663.49 |
| 76942 |
|
15 |
12 |
$644.35 |
| 69210 |
|
25 |
25 |
$599.70 |
| 29540 |
|
27 |
26 |
$560.53 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
46 |
45 |
$502.85 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
15 |
15 |
$450.32 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
15 |
15 |
$448.68 |
| 87535 |
|
15 |
15 |
$448.68 |
| 87538 |
|
15 |
15 |
$448.68 |
| 87529 |
|
15 |
15 |
$448.68 |
| 87516 |
|
15 |
15 |
$448.68 |
| 87521 |
Neg quan hep c or qual rna |
15 |
15 |
$448.68 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
15 |
15 |
$424.56 |
| 87563 |
|
15 |
15 |
$416.90 |
| 90688 |
|
36 |
36 |
$385.23 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
15 |
15 |
$351.13 |
| 97750 |
|
74 |
62 |
$324.91 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
12 |
12 |
$271.39 |
| 73610 |
|
13 |
12 |
$265.96 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
35 |
28 |
$262.24 |
| 92567 |
|
28 |
25 |
$261.15 |
| 88112 |
|
210 |
168 |
$257.91 |
| 92541 |
|
31 |
26 |
$235.35 |
| 93000 |
|
13 |
13 |
$206.94 |
| 98966 |
|
18 |
12 |
$187.45 |
| 87500 |
|
12 |
12 |
$185.11 |
| 86780 |
|
15 |
15 |
$171.37 |
| 51702 |
|
17 |
14 |
$49.13 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
51 |
39 |
$44.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
4,642 |
3,933 |
$4.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
125 |
118 |
$0.27 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
1,143 |
971 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
1,331 |
1,131 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
416 |
351 |
$0.00 |
| 1160F |
|
155 |
135 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
133 |
121 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
132 |
110 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
36 |
35 |
$0.00 |
| 3725F |
|
19 |
14 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
1,463 |
1,246 |
$0.00 |
| G8755 |
Most recent diastolic blood pressure >= 90 mmhg |
64 |
52 |
$0.00 |
| 1036F |
|
101 |
87 |
$0.00 |
| 3008F |
|
174 |
150 |
$0.00 |
| G8950 |
Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented |
14 |
12 |
$0.00 |